Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Both Retatrutide and Cagrilintide are investigational compounds currently undergoing Phase III clinical trials and are not yet approved for clinical use
Cytosolic acetyl-coenzyme A is a signalling metabolite to control mitophagy
Chemical Information CAS Number 137525-51-0 Secondary CAS 1356647-49-2 Purity 99%+ HPLC Verified Molecular Formula C 62 H 98 N 16 O 22 Molar Mass 1419.5347 g/mol Form Factor Lyophilized Powder Synonyms Research Applications Gastroenterology Research: BPC-157 is investigated in preclinical gastrointestinal models for its potential influence on mucosal cytoprotection, gastric lesion repair, NSAID-associated tissue injury, and intestinal barrier function
It conjugates with various toxins, drugs, and metabolic waste products, making them water-soluble and easier to excrete
That said, BPC-157 is still a research chemical , not FDA-approved, and long-term human data is limited
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 25.39
US$ 22.52
US$ 20.78
US$ 20.75
US$ 21.45
